Financial insights of ORMP

MyFinsight

For the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Income Statement	2025-09-30	2025-06-30	2024-09-30
Revenues	-	0	-
Cost of revenue	-	0	-
Gross profit	-	0	-
Research and development expenses	1,153	1,034	2,242
General and administrative expenses	1,274	1,455	847
Operating loss	-2,427	-2,489	-3,089
Other income, net	408	257	-
Financial income (loss), net	61,470	15,366	-15,420
Interest expenses	-	0	-
Income (loss) before tax expenses	59,451	13,134	-18,509
Tax expenses	11,062	-126	1,133
Net income (loss)	48,389	13,260	-19,642
Non-controlling interests	-6	-28	-23
Companys stockholders	48,395	13,288	-19,619

Basic income (loss) per share of common stock (in dollars per share)	1.16	0.32	-0.48
Diluted income (loss) per share of common stock (in dollars per share)	1.13	0.31	-0.48
Weighted average number of shares of common stock used in computing basic income per share of common stock (in shares)	41,756,301	41,743,486	40,896,845
Weighted average number of shares of common stock used in computing diluted income per share of common stock (in shares)	42,774,504	42,609,425	40,896,845